🚀 VC round data is live in beta, check it out!
Nano X Imaging Valuation Multiples
Discover revenue and EBITDA valuation multiples for Nano X Imaging and similar public comparables like eWeLL, Kusurinomadoguchi, Lucid Diagnostics, Bioneer and more.
Nano X Imaging Overview
About Nano X Imaging
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
Founded
2018
HQ
Employees
165
Website
Financials (LTM)
EV
$161M
Nano X Imaging Financials
Nano X Imaging reported last 12-month revenue of $19M.
In the same LTM period, Nano X Imaging generated ($7M) in gross profit and had net loss of ($50M).
Revenue (LTM)
Nano X Imaging P&L
In the most recent fiscal year, Nano X Imaging reported revenue of $11M and EBITDA of ($45M).
Nano X Imaging expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $19M | XXX | $11M | XXX | XXX | XXX |
| Gross Profit | ($7M) | XXX | ($11M) | XXX | XXX | XXX |
| Gross Margin | (36%) | XXX | (94%) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($45M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (399%) | XXX | XXX | XXX |
| EBIT Margin | (276%) | XXX | (503%) | XXX | XXX | XXX |
| Net Profit | ($50M) | XXX | ($54M) | XXX | XXX | XXX |
| Net Margin | (266%) | XXX | (474%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Nano X Imaging Stock Performance
Nano X Imaging has current market cap of $198M, and enterprise value of $161M.
Market Cap Evolution
Nano X Imaging's stock price is $2.85.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $161M | $198M | 0.0% | XXX | XXX | XXX | $-0.77 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNano X Imaging Valuation Multiples
Nano X Imaging trades at 8.6x EV/Revenue multiple, and (3.6x) EV/EBITDA.
EV / Revenue (LTM)
Nano X Imaging Financial Valuation Multiples
As of April 20, 2026, Nano X Imaging has market cap of $198M and EV of $161M.
Equity research analysts estimate Nano X Imaging's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nano X Imaging has a P/E ratio of (4.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $198M | XXX | $198M | XXX | XXX | XXX |
| EV (current) | $161M | XXX | $161M | XXX | XXX | XXX |
| EV/Revenue | 8.6x | XXX | 14.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (3.6x) | XXX | XXX | XXX |
| EV/EBIT | (3.1x) | XXX | (2.8x) | XXX | XXX | XXX |
| EV/Gross Profit | (23.8x) | XXX | (15.2x) | XXX | XXX | XXX |
| P/E | (4.0x) | XXX | (3.7x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (4.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nano X Imaging Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Nano X Imaging Margins & Growth Rates
Nano X Imaging's revenue in the last 12 month grew by 111%.
Nano X Imaging's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Nano X Imaging Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 111% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (399%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (6%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 31% | XXX | 30% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 117% | XXX | 214% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 104% | XXX | 179% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 409% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Nano X Imaging Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics and Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Nano X Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| eWeLL | XXX | XXX | XXX | XXX | XXX | XXX |
| Kusurinomadoguchi | XXX | XXX | XXX | XXX | XXX | XXX |
| Lucid Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioneer | XXX | XXX | XXX | XXX | XXX | XXX |
| MTI Ltd. | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nano X Imaging M&A Activity
Nano X Imaging acquired XXX companies to date.
Last acquisition by Nano X Imaging was on XXXXXXXX, XXXXX. Nano X Imaging acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Nano X Imaging
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNano X Imaging Investment Activity
Nano X Imaging invested in XXX companies to date.
Nano X Imaging made its latest investment on XXXXXXXX, XXXXX. Nano X Imaging invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Nano X Imaging
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nano X Imaging
| When was Nano X Imaging founded? | Nano X Imaging was founded in 2018. |
| Where is Nano X Imaging headquartered? | Nano X Imaging is headquartered in United States. |
| How many employees does Nano X Imaging have? | As of today, Nano X Imaging has over 165 employees. |
| Who is the CEO of Nano X Imaging? | Nano X Imaging's CEO is Erez Meltzer. |
| Is Nano X Imaging publicly listed? | Yes, Nano X Imaging is a public company listed on Nasdaq. |
| What is the stock symbol of Nano X Imaging? | Nano X Imaging trades under NNOX ticker. |
| When did Nano X Imaging go public? | Nano X Imaging went public in 2020. |
| Who are competitors of Nano X Imaging? | Nano X Imaging main competitors are eWeLL, Kusurinomadoguchi, Lucid Diagnostics, Bioneer. |
| What is the current market cap of Nano X Imaging? | Nano X Imaging's current market cap is $198M. |
| What is the current revenue of Nano X Imaging? | Nano X Imaging's last 12 months revenue is $19M. |
| What is the current revenue growth of Nano X Imaging? | Nano X Imaging revenue growth (NTM/LTM) is 111%. |
| What is the current EV/Revenue multiple of Nano X Imaging? | Current revenue multiple of Nano X Imaging is 8.6x. |
| Is Nano X Imaging profitable? | No, Nano X Imaging is not profitable. |
| What is the current net income of Nano X Imaging? | Nano X Imaging's last 12 months net income is ($50M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.